HCW Biologics Inc. SEC filings HCWB

HCW Biologics Inc. has 340 filings in SEC EDGAR's recent list, going back to Oct 19, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 24, 2026 (material agreement, unregistered share sale, regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
DEF 14A Proxy statement Oct 1, 2026 Oct 1, 2026
PRE 14A Preliminary proxy statement Sep 8, 2026 Sep 4, 2026
DEF 14A Proxy statement Apr 28, 2026 Apr 28, 2026
PRE 14A Preliminary proxy statement Apr 17, 2026 Apr 17, 2026
DEF 14A Proxy statement Mar 13, 2026 Mar 13, 2026
PRE 14A Preliminary proxy statement Mar 3, 2026 Mar 3, 2026
DEF 14A Proxy statement Apr 28, 2025 Jun 17, 2025
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Feb 21, 2025 Mar 31, 2025
PRE 14A Preliminary proxy statement Feb 11, 2025 Mar 31, 2025
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 14, 2024
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 Jun 13, 2023
DEF 14A Proxy statement Apr 25, 2022 Jun 15, 2022

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HCWB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Miramar, FL
SEC filer status
, Emerging growth company
SEC CIK
1828673

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.